 Investorplace.com |
UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer
Reuters May 21 (Reuters) – A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease … New Asthma Drug Generates Excitement For Patients — And Its Maker Antibody Gets High Marks for Asthma Control – MedPage Today Monoclonal Antibody Dupilumab Safe And Effective In Asthma Phase IIa Trial |
View full post on asthma – Google News